# MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
> **ANDA208237** · Abbreviated New Drug Application (Generic) · Sponsor: ANI PHARMS · Approved 2023-12-15
## Drug
- **FDA Application Number:** ANDA208237
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
- **Generic name:** MEMANTINE AND DONEPEZIL HYDROCHLORIDES
- **Active ingredients:** DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ANI PHARMS
- **Manufacturer:** ANI Pharmaceuticals, Inc.
- **First approval:** 2023-12-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208237)
---
*MORVS · CC0 1.0*